CA2598889A1 - Compositions and methods for classifying biological samples - Google Patents

Compositions and methods for classifying biological samples Download PDF

Info

Publication number
CA2598889A1
CA2598889A1 CA002598889A CA2598889A CA2598889A1 CA 2598889 A1 CA2598889 A1 CA 2598889A1 CA 002598889 A CA002598889 A CA 002598889A CA 2598889 A CA2598889 A CA 2598889A CA 2598889 A1 CA2598889 A1 CA 2598889A1
Authority
CA
Canada
Prior art keywords
epitopes
class
sample
samples
nsclc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002598889A
Other languages
English (en)
French (fr)
Inventor
Toomas Neuman
Mehis Pold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CeMines Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2598889A1 publication Critical patent/CA2598889A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02Peptides being immobilised on, or in, an organic carrier
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14Peptides being immobilised on, or in, an inorganic carrier
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002598889A 2005-02-24 2006-02-24 Compositions and methods for classifying biological samples Abandoned CA2598889A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65685905P 2005-02-24 2005-02-24
US60/656,859 2005-02-24
PCT/US2006/006431 WO2006091734A2 (en) 2005-02-24 2006-02-24 Compositions and methods for classifying biological samples

Publications (1)

Publication Number Publication Date
CA2598889A1 true CA2598889A1 (en) 2006-08-31

Family

ID=36928007

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002598889A Abandoned CA2598889A1 (en) 2005-02-24 2006-02-24 Compositions and methods for classifying biological samples

Country Status (11)

Country Link
US (1) US20090075832A1 (enExample)
EP (1) EP1859266A4 (enExample)
JP (1) JP2008532014A (enExample)
KR (1) KR20080003321A (enExample)
CN (1) CN101160524A (enExample)
AU (1) AU2006216683A1 (enExample)
CA (1) CA2598889A1 (enExample)
IL (1) IL185458A0 (enExample)
MX (1) MX2007010349A (enExample)
RU (1) RU2007135030A (enExample)
WO (1) WO2006091734A2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002322009A1 (en) 2001-05-18 2002-12-03 Mayo Foundation For Medical Education And Research Chimeric antigen-specific t cell-activating polypeptides
US20060222656A1 (en) 2005-04-01 2006-10-05 University Of Maryland, Baltimore MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
ES2444695T3 (es) * 2006-06-23 2014-02-26 Alethia Biotherapeutics Inc. Polinucleótidos y polipéptidos implicados en el cáncer
WO2008053573A1 (fr) 2006-10-30 2008-05-08 National University Corporation Hokkaido University Remède pour néoplasme malin
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
EP2201024A1 (en) * 2007-08-28 2010-06-30 Ramot At Tel Aviv University Peptides inducing a cd4i conformation in hiv gp120 while retaining vacant cd4 binding site
TWI466680B (zh) * 2008-08-01 2015-01-01 Oncotherapy Science Inc Melk抗原決定位胜肽及含此胜肽的疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
KR20110084280A (ko) 2008-11-03 2011-07-21 알레시아 바이오쎄라퓨틱스 인코포레이티드 종양 항원의 생물 활성을 특이적으로 차단하는 항체
GB0823366D0 (en) * 2008-12-22 2009-01-28 Uni I Oslo Synthesis
KR101067815B1 (ko) * 2009-02-05 2011-09-27 서울대학교산학협력단 제1형 당뇨병의 신규한 진단 마커
CN105911275B (zh) 2009-08-14 2018-06-29 加利福尼亚大学董事会 诊断自闭症的试剂盒
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells
TWI485245B (zh) 2010-01-25 2015-05-21 Oncotherapy Science Inc 經修飾之melk胜肽及含此胜肽之疫苗
EP2691421B1 (en) 2011-03-31 2016-11-09 Alethia Biotherapeutics Inc. Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
EP2745115B1 (de) * 2011-08-19 2016-05-18 Protagen AG Neues verfahren zur diagnostik von hochaffinen bindern und markersequenzen
WO2013031757A1 (ja) * 2011-08-29 2013-03-07 東レ株式会社 膵癌、乳癌、肺癌又は前立腺癌の検出用マーカー及び検査方法
WO2013104050A2 (en) 2012-01-09 2013-07-18 Alethia Biotherapeutics Inc. Method for treating breast cancer
US20130183242A1 (en) * 2012-01-18 2013-07-18 University Of Connecticut Methods for identifying tumor-specific polypeptides
GB201319446D0 (en) 2013-11-04 2013-12-18 Immatics Biotechnologies Gmbh Personalized immunotherapy against several neuronal and brain tumors
WO2015172843A1 (en) * 2014-05-16 2015-11-19 Biontech Diagnostics Gmbh Methods and kits for the diagnosis of cancer
WO2015179469A2 (en) * 2014-05-20 2015-11-26 Kiromic, Llc Methods and compositions for treating malignancies with dendritic cells
US10526397B2 (en) 2015-01-21 2020-01-07 Inhibrx, Inc. Non-immunogenic single domain antibodies
GB201505305D0 (en) * 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
EP4300101A3 (en) 2015-06-26 2024-03-20 The Regents Of The University Of California Antigenic peptides and uses thereof for diagnosing and treating autism
IL292037A (en) 2015-07-16 2022-06-01 Inhibrx Inc Multivalent and multispecific dr5-binding fusion proteins and uses thereof
HK1258386A1 (zh) * 2015-10-05 2019-11-08 Immatics Biotechnologies Gmbh 用於小细胞肺癌和其他癌症免疫治疗的肽和肽组合物
EP3193173A1 (en) * 2016-01-14 2017-07-19 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Serological autoantibodies as biomarker for colorectal cancer
GB201604458D0 (en) * 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against cancers
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
CR20210128A (es) * 2017-01-27 2021-04-26 Immatics Biotechnologies Gmbh Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de ovario y otros tipos de cancer (divisional exp. 2019-388)
CN108948184B (zh) * 2017-05-22 2021-04-23 香雪生命科学技术(广东)有限公司 一种识别衍生自prame抗原短肽的t细胞受体
CN109400697B (zh) * 2017-08-17 2021-04-23 香雪生命科学技术(广东)有限公司 一种识别prame抗原短肽的tcr及其相关组合物
EP3756680A1 (en) * 2019-06-26 2020-12-30 Universitat de Lleida Intermediate filament-derived peptides and their uses
EP3999525A4 (en) * 2019-07-15 2023-08-09 Geisinger Health System COMPOSITIONS AND METHODS FOR THE TREATMENT OF BREAST CANCER WITH A NOVEL CAPER ALPHA MLL1 COMPLEX
CN110922492B (zh) * 2019-12-18 2022-02-15 重庆医科大学 融合肽、ctp介导的诱导cml细胞免疫应答的dc疫苗及其制备方法
CN111337678B (zh) * 2020-02-21 2023-06-06 杭州凯保罗生物科技有限公司 与肿瘤免疫治疗效果相关的生物标志物及其应用
CN116773798A (zh) * 2023-06-16 2023-09-19 北京三品医疗科技有限公司 多肽的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
EP1337667A2 (en) * 2000-11-16 2003-08-27 Cedars-Sinai Medical Center Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
WO2002073209A2 (de) * 2001-03-10 2002-09-19 Affina Immuntechnik Gmbh Verfahren zur identifikation von immunreaktiven epitopen auf proteinen
WO2002084249A2 (en) * 2001-04-10 2002-10-24 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic and diagnostic uses of antibody specificity profiles
WO2003042357A2 (en) * 2001-09-28 2003-05-22 Incyte Genomics, Inc. Enzymes
EP1578970A1 (de) * 2002-12-23 2005-09-28 Hans-Jürgen Thiesen Human-autoantigene und deren verwendung
EP1583504A4 (en) * 2002-12-26 2008-03-05 Cemines Llc METHOD AND COMPOSITIONS FOR DIAGNOSIS, FORECAST AND TREATMENT OF CANCER

Also Published As

Publication number Publication date
US20090075832A1 (en) 2009-03-19
EP1859266A4 (en) 2010-07-28
AU2006216683A1 (en) 2006-08-31
CN101160524A (zh) 2008-04-09
WO2006091734A9 (en) 2006-10-19
MX2007010349A (es) 2008-04-09
RU2007135030A (ru) 2009-03-27
EP1859266A2 (en) 2007-11-28
WO2006091734A3 (en) 2007-02-08
IL185458A0 (en) 2008-01-06
KR20080003321A (ko) 2008-01-07
WO2006091734A2 (en) 2006-08-31
JP2008532014A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
US20090075832A1 (en) Compositions and Methods for Classifying Biological Samples
Vlahou et al. A novel approach toward development of a rapid blood test for breast cancer
M’Koma et al. Detection of pre-neoplastic and neoplastic prostate disease by MADI profiling of urine
US20080081339A1 (en) Tumor associated markers in the diagnosis of prostate cancer
JP6600637B2 (ja) 膵臓がんを決定するための方法、アレイおよびそれらの使用
Lacombe et al. Use of autoantibodies to detect the onset of breast cancer
US20060088894A1 (en) Prostate cancer biomarkers
EP2951592A1 (en) Autoantibody signature for the early detection of ovarian cancer
US20080026410A1 (en) Biomarkers for Bladder Cancer
AU2010264067A2 (en) A method and system for the detection of cancer
JP6674889B2 (ja) 前立腺がんに対するバイオマーカー検出における使用のための方法とアレイ
WO2010115077A2 (en) Biomarker panels for barrett's esophagus and esophageal adenocarcinoma
AU2005287074A1 (en) Biomarkers for breast cancer
CN113702636B (zh) 血浆自身抗体标志物在乳腺癌早期诊断及其分子亚型表征中的应用
Abols et al. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer
HK1120108A (en) Compositions and methods for classifying biological samples
WO2010063761A1 (en) An in-vitro method or assay for detecting a tumor or a cancerous disease by screening for antibodies
US20210080465A1 (en) SH2 domain-based prognostic biomarker for chronic lymphocytic leukemia
WO2013166480A1 (en) Detectors of serum biomarkers for predicting ovarian cancer recurrence
JP7575375B2 (ja) 関節リウマチ自己抗体レパートリーのプロファイリング及びそのためのペプチド分類子
AU2005274726A1 (en) Biomarkers for bladder cancer
WO2006071843A2 (en) Biomarkers for breast cancer
CN121410263A (zh) 胆道癌免疫治疗相关的尿液蛋白标志物及其应用
Sreekumar et al. 16 Humoral Response Profiling Using Protein Microarrays

Legal Events

Date Code Title Description
FZDE Discontinued